Latest Vertex Pharmaceuticals News & Updates

See the latest news and media coverage for Vertex. We track all announcements, press releases, and industry mentions in real time, all in one place.

Vertex Pharmaceuticals (Vertex)

Biopharmaceutical company

Latest news about Vertex Pharmaceuticals (Vertex)

April 22 Vertex

Vertex enters reimbursement agreement in Chile

The agreement with Chile's Ministry of Health enables broad access to a cystic fibrosis therapy for eligible patients aged six and older.
April 1 Vertex

Vertex announces FDA approval for ALYFTREK and TRIKAFTA label extensions

Expands eligibility to ~95% of CF patients in the US, including 800 more for the first time. Supported by data from hundreds of variants.
March 9 Vertex

Vertex announces positive Phase 3 trial results for povetacicept

Povetacicept achieves 52% proteinuria reduction, meets all endpoints in IgAN trial, and plans BLA submission by March end. Well tolerated with no serious drug-related AEs.
March 5 Vertex

Vertex presents new data on JOURNAVX

Phase 4 study shows over 90% of patients opioid-free after aesthetic and reconstructive surgeries. Data accepted for oral presentation at AAPM meeting.

Yesterday Newser

Vertex Pharmaceuticals (VRTX) - FDA ALYFTREK Label Expansion Reinforces Core Cystic Fibrosis...

We help you distinguish between sustainable trends and temporary price spikes that could trap unwary investors. This analysis evaluates Vertex Pharmaceuticals (VRTX) following two recent...
April 30 The Globe and Mail

Vertex Director Upadhyay to Step Down Amid CFO Move

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
April 29 The Business Journals

King of Prussia public company Vertex to lay off 9% of workforce in shift to AI

The King of Prussia company's CEO said the layoffs are necessary in an industry being reshaped by new technologies, accelerating regulatory change, and intensifying competition.
April 27 CBC

Price of cystic fibrosis drug Kalydeco could drop with deal

An expensive drug hailed as life-changing for people with a rare strain of cystic fibrosis is a step closer to being available to people in...

Never miss news about Vertex

Track Vertex and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Vertex and other trending companies.